ImageneBio (IMA) Price to Book (2021 - 2025)
ImageneBio's (IMA) quarterly Price to Book came in at 0.44 in Q4 2025, up 189.66% year-over-year from 0.15 in Q4 2024, and down 11.08% quarter-over-quarter from 0.5 in Q3 2025.
Analysis
ImageneBio (IMA) Price to Book (2021 - 2025) Analysis & Trends
ImageneBio has disclosed Price to Book across 5 years of filings, most recently posting 0.44 for Q4 2025.
- In Q4 2025, Price to Book rose 189.66% year-over-year to 0.44; the TTM figure through Dec 2025 stood at 0.44 (up 189.66% YoY), while the FY2025 annual figure was 0.21, up 142.28% from the prior year.
- Price to Book came in at 0.44 for Q4 2025 at ImageneBio, down from 0.5 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 2.33 in Q2 2021 to a low of 0.75 in Q4 2023.
- Average Price to Book over 5 years is 0.58, with a median of 0.58 recorded in 2022.
- Year-over-year, Price to Book plunged 214.88% in 2023 and soared 190.93% in 2025.
- Over 5 years, Price to Book stood at 1.69 in 2021, then plunged by 61.13% to 0.66 in 2022, then slumped by 214.88% to 0.75 in 2023, then surged by 34.62% to 0.49 in 2024, then surged by 189.66% to 0.44 in 2025.
- Per Business Quant data, the three most recent Price to Book figures were 0.44 in Q4 2025, 0.5 in Q3 2025, and 0.36 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.44 |
| Sep 30, 2025 | 0.50 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -0.55 |
| Jun 30, 2024 | -0.54 |
| Mar 31, 2024 | -0.50 |
| Dec 31, 2023 | -0.75 |
| Sep 30, 2023 | 1.23 |
| Jun 30, 2023 | 1.77 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 0.81 |
| Jun 30, 2022 | 0.92 |
| Mar 31, 2022 | 1.14 |
| Dec 31, 2021 | 1.69 |
| Sep 30, 2021 | 2.23 |
| Jun 30, 2021 | 2.33 |
| Mar 31, 2021 | 0.48 |